Profilaxis de la infección por citomegalovirus en el trasplante de páncreas

White, 2009, Pancreas transplantation, Lancet, 373, 1808, 10.1016/S0140-6736(09)60609-7 Organización Nacional de Trasplantes de España. Trasplante pancreático en España, 2010. Disponible en: http://www.ont.es/infesp/Memorias/Dosier_pancreas_2010_web.pdf. Singh, 2008, Advances in immunosuppression for pancreas transplantation, Curr Opin Organ Transplant, 13, 79, 10.1097/MOT.0b013e3282f2fd91 Axelrod, 2005, Reduction of CMV disease with steroid-free immunesuppression in simultaneous pancreas-kidney transplant recipients, Am J Transplant, 5, 1423, 10.1111/j.1600-6143.2005.00855.x Keay, 1999, CMV infection and disease in kidney and pancreas transplant recipients, Transpl Infect Dis, 1, 19 Rayes, 2007, Long-term outcome of cytomegalovirus infection in simultaneous pancreas-kidney transplant recipients without ganciclovir prophylaxis, Transpl Int, 20, 974, 10.1111/j.1432-2277.2007.00526.x Ricart, 2005, Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation, Nephrol Dial Transplant, 20, ii25, 10.1093/ndt/gfh1079 Stratta, 1995, Experience with protocol biopsies after solitary pancreas transplantation, Transplantation, 60, 1431, 10.1097/00007890-199560120-00011 López-Medrano, 2009, Preemptive therapy is not adequate for prevention of cytomegalovirus disease in pancreas-kidney transplant recipients, Transpl Infect Dis, 11, 400, 10.1111/j.1399-3062.2009.00416.x Kotton, 2010, Management of cytomegalovirus infection in solid organ transplantation, Nat Rev Nephrol, 6, 711, 10.1038/nrneph.2010.141 San Juan, 2008, Impact of current transplantation. Management on the development of cytomegalovirus disease after renal transplantation, Clin Infect Dis, 47, 875, 10.1086/591532 Burke, 2004, Prospective, randomized trial of the effect of antibody induction in simultaneous pancreas and kidney transplantation: three-year results, Transplantation, 77, 1269, 10.1097/01.TP.0000123903.12311.36 Maglione, 2010, Cytomegalovirus mismatch as major risk factor for delayed graft function after pancreas transplantation, Transplantation, 90, 666, 10.1097/TP.0b013e3181ea67a1 Neidlinger, 2010, Incidence of and risk factors for posttransplant diabetes mellitus after pancreas transplantation, Am J Transplant, 10, 398, 10.1111/j.1600-6143.2009.02935.x Kaufman, 2003, Prospective, randomized, multi-center trial of antibody induction therapy in simultaneous pancreas-kidney transplantation, Am J Transplant, 3, 855, 10.1034/j.1600-6143.2003.00160.x Kotton, 2010, International consensus guidelines on the management of cytomegalovirus in solid organ transplantation, Transplantation, 89, 779, 10.1097/TP.0b013e3181cee42f Torre-Cisneros, 2011, Recomendaciones GESITRA-SEIMC/REIPI sobre manejo de la infección por citomegalovirus en pacientes trasplantados de órgano sólido, Enferm Infecc Microbiol Clin, 29, 735, 10.1016/j.eimc.2011.05.022 Luan, 2010, Choice of induction regimens on the risk of cytomegalovirus infection in donor-positive and recipientnegative kidney transplant recipients, Transpl Infect Dis, 12, 473, 10.1111/j.1399-3062.2010.00532.x Magliocca, 2008, A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation, Am J Transplant, 8, 1702, 10.1111/j.1600-6143.2008.02299.x Hodson, 2005, Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials, Lancet, 365, 2105, 10.1016/S0140-6736(05)66553-1 Weng, 2007, Oral ganciclovir versus low-dose valganciclovir for prevention of cytomegalovirus disease in recipients of kidney and pancreas transplants, Transplantation, 83, 290, 10.1097/01.tp.0000251371.34968.ca Humar, 2010, The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients, Am J Transplant, 10, 1228, 10.1111/j.1600-6143.2010.03074.x Luan, 2009, Six-month prophylaxis is cost effective in transplant patients at high risk for cytomegalovirus infection, J Am Soc Nephrol, 20, 2449, 10.1681/ASN.2008111166